Share this Post!

The Food and Drug Administration (FDA) warns the public from purchasing and using the unnotified and adulterated TCCA product, which was found to contain 8.4 percent of di-(2-ethylhexyl) phthalate (DEHP) and 0.5 percent diisononyl phthalate (DINP). Such ingredients are not allowed to have concentrations of more than 0.1 percent as per Administrative Order No. 2009-005-A s. 2011. (Please see attachment for the particulars of the adulterated TCCA: )


Potential hazards may come from ingredients that are found to contain beyond the allowable limit of an ingredient such as Phthalate to be part of TCCA products. The use of substandard and possibly adulterated TCCA products may result to health risks including but not limited to endocrine disruption and reproductive or developmental effects in relation to exposure to these compounds.

In light of the foregoing, the public is advised not to purchase the aforementioned adulterated product. Moreover, the public is advised to always check if a TCCA product is notified with the FDA. The FDA website ( has a Search feature which may be used by typing in the name of the product before purchasing.

All concerned establishments are warned not to distribute adulterated TCCA products.

All FDA Regional Field Offices and Regulatory Enforcement Units, in coordination with law enforcement agencies and Local Government Units, are requested to ensure that violative products are not sold or made available in the market or areas of jurisdiction.

Kindly contact the FDA Center for Cosmetics Regulation and Research (CCRR) through e­mail at [email protected].ph, or call (02) 857-1900 loc. 8113 or 8107.

To report any sale or distribution of the afore-mentioned TCCA, the online reporting facility, eReport can be accessed at

Dissemination of this advisory to all concerned is hereby requested.

Attachment:-> FDA Advisory No.2020-042